drugset / Trial / NCT03587025

Preemptive Analgesia With Amitryptyline for Prevention of Pain in Women After Hysterectomy

NCT03587025

Phase 3 Completed 150 enrolled University of Campinas, Brazil
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The purpose of this study is to determine whether amitryptyline is effective in the prevention of pain in women after a total abdominal hysterectomy.

Timeline

Start
2015-06-01
Primary completion
2018-10-30
Completion
2018-10-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Amitriptyline Small molecule 75 mg Oral

Indications

No indication recorded.